Draslovka has been reimagining what’s possible with the CN family of chemicals for more than 100 years. We are a Czech family company, driven by an international team working across the world with a conscious ambition to be the best at what they do.About the company
Draslovka strongly condemns the invasion of Ukraine by the Russian Federation, which has led to tragic loss of life and has brought open war again to Europe.
Oaktree will invest US$150m in Draslovka providing preferred equity capital to support the Company’s growth strategy. Draslovka also today announces the completion of the acquisition of Australia based Mining & Process Solutions (“MPS”), a business that owns the exclusive rights to the Glycine Leaching process.
This completion makes Draslovka the global leader in the manufacture, technological development, and distribution of hydrogen cyanide (HCN) based specialty chemical products.